AMBQ

Ambiq Micro, Inc.
NYSETECHNOLOGYSEMICONDUCTORS

Key Statistics

Market Cap
$1.69B
P/E Ratio
—
EPS
$-4.44
Beta
—
52W High
$91.61
52W Low
$22.12
50-Day MA
$64.14
200-Day MA
$50.16
Dividend Yield
—
Profit Margin
-37.80%
Forward P/E
—
PEG Ratio
—

About Ambiq Micro, Inc.

Ambiq Micro, Inc. develops ultra-low-power integrated circuits for power-sensitive applications. The company is headquartered in Austin, Texas.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$97.87M
Gross Profit (TTM)$42.69M
EBITDA$-35.49M
Operating Margin-25.70%
Return on Equity-15.50%
Return on Assets-10.10%
Revenue/Share (TTM)$5.35
Book Value$16.76
Price-to-Book3.73
Price-to-Sales (TTM)17.25
EV/Revenue11.71
EV/EBITDA—
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)89.70%
Shares Outstanding$24.18M
Float$21.67M
% Insiders5.08%
% Institutions81.72%

Historical Volatility

HV 10-Day
65.93%
HV 20-Day
64.27%
HV 30-Day
66.34%
HV 60-Day
77.81%
HV Rank
44.0%

Volatility is currently contracting

Analyst Ratings

Consensus ($85.67 target)
1
Strong Buy
3
Buy
2
Hold

Latest News

Personal AI Assistants: How to Get Started & How to Invest

Personal AI assistants are moving beyond answering questions to carrying out everyday tasks through several steps. Meta Platforms' (META) Muse agent is one example that has taken the world by storm over the past week.

ETF Trends9/23/2026Neutral
Ambiq Micro Q2 Earnings Call Highlights

Ambiq Micro NYSE: AMBQ reported second-quarter 2026 net sales of $33.9 million, up 89.7% from a year earlier, as demand for edge artificial intelligence applications accelerated across its customer base and product portfolio.

MarketBeat8/11/2026Neutral
Wasatch Micro Cap Fund Q2 2026 Contributors And Detractors

The leading contributor was Ambiq Micro, Inc. (AMBQ) , a designer of ultra-low power semiconductor solutions that went public in July of 2025. Suncrete's stock moved higher in the wake of strong first quarter revenue growth. TriSalus posted a significant miss on revenues and lowered guidance during the quarter, citing the impact of a Salesforce (CRM) reorganization and delayed FDA review of its next-generation device.

Seeking Alpha8/7/2026Negative

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMBQ and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More TECHNOLOGY Stocks

Data last updated: 9/26/2026